Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Healthy Returns
Recent news which mentions Healthy Returns
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
Health & Science
Vertex Pharmaceuticals Inc
Hacking
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Astellas Pharma Inc
Healthy Returns
Health care industry
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Biotech and Pharmaceuticals
Social issues
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Health & Science
Healthy Returns
Health care industry
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Berkshire Hathaway Inc
Biotech and Pharmaceuticals
Social issues
From
CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
August 27, 2024
Tags
Science
Social issues
Pfizer Inc
From
CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
August 20, 2024
Tags
Healthy Returns
Health care industry
Moderna Inc
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Biotech and Pharmaceuticals
Health & Science
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Johnson & Johnson
Pfizer Inc
Abbvie Inc
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Biotech and Pharmaceuticals
Altimmune Inc
Science
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Bristol/Myers Squibb Co
Health & Science
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Merck & Co Inc
Novo Nordisk A/S
Science
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Health & Science
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Altimmune Inc
Biotech and Pharmaceuticals
Technology
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Viking Therapeutics Inc
Health & Science
Gilead Sciences Inc
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Healthy Returns
Health care industry
Health & Science
From
CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
June 12, 2024
Tags
Moderna Inc
Microsoft Corp
Health & Science
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Merck & Co Inc
Science
Johnson & Johnson
From
CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
Tags
Health care industry
Healthy Returns
Moderna Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Health & Science
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Social issues
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
May 01, 2024
Tags
Biotech and Pharmaceuticals
UnitedHealth Group Inc
Alvotech SA
From
CNBC.com News
Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
April 23, 2024
Tags
Kyverna Therapeutics Inc
Alto Neuroscience Inc
UnitedHealth Group Inc
From
CNBC.com News
Healthy Returns: U.S. drug shortages reach record high, hitting Wegovy, ADHD medications
April 16, 2024
Tags
UnitedHealth Group Inc
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 09, 2024
Tags
Health & Science
Bristol/Myers Squibb Co
Health care industry
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
March 26, 2024
Tags
Biotech and Pharmaceuticals
Health & Science
GSK plc
From
CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
Tags
Science
Biotech and Pharmaceuticals
Aligos Therapeutics Inc
From
CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
March 13, 2024
Tags
Health & Science
Healthy Returns
Health care industry
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.